Amarin Corp Plc (AMRN)

[lettruthringout]

French Committee makes reimbursement recommendations

Opinion in favor of reimbursement only in adult patients on treatment with a statin at the maximum tolerated dose, at very high cardiovascular risk due to established cardiovascular disease (secondary prevention) and presenting with moderately high hypertriglyceridemia (≥ 150 and < 500 mg/dL ).

Opinion against reimbursement in the other populations of the indication including patients with severe hypertriglyceridemia (≥ 500 mg/dL) and those with diabetes and at least one other cardiovascular risk factor (primary prevention).

https://www.investorvillage.com/smbd.asp?mb=2294&mn=8875&pt=msg&mid=22917240